Spectral AI Q4 Revenue $3.8M Beats Expectations
Reports Q4 revenue $3.8M, consensus $2.92M. Q4 EPS included a $4.0M gain in the fair value of the Company's warrant liability. "2025 was a pivotal year for Spectral AI, highlighted by the submission of our De Novo 510 application to the FDA of our DeepView System for burn indication," said Vincent Capone, CEO of Spectral AI. "We continue to make significant progress along numerous fronts in preparation for the anticipated commercialization of this innovative diagnostic device. The reception of our technology at burn conferences in the U.S., UK, and Europe has been exceptional."
Trade with 70% Backtested Accuracy
Analyst Views on MDAI
About MDAI
About the author


- Event Participation: Spectral AI will showcase its DeepView® System at the American Burn Association Annual Meeting from April 14-17, 2026, in Orlando, Florida, attracting over 2,200 clinicians and researchers, which will enhance the company's influence in the burn care industry.
- Product Demonstration: The DeepView System combines multispectral imaging with a proprietary AI algorithm to rapidly assess the healing potential of burn wounds, enabling clinicians to make faster treatment decisions, which is expected to significantly improve patient outcomes and reduce healthcare costs.
- FDA Application Progress: Spectral AI submitted its De Novo 510(k) marketing clearance application for the DeepView System to the FDA in June 2025, and if approved, it will further accelerate the product's market entry and strengthen the company's competitive position in medical diagnostics.
- Industry Recognition: Spectral AI has been named one of TIME's Top HealthTech Companies of 2025, highlighting its leadership in medical technology innovation and is expected to attract more investor interest in its future growth potential.
- New CFO Appointment: Spectral AI announced the appointment of David McGuire as CFO effective May 4, 2026, indicating the company's strategic emphasis on financial management with McGuire's over 20 years of finance and accounting experience.
- Extensive Industry Background: McGuire most recently served as CAO at Solo Brands and held the positions of deputy CFO and chief accounting officer at EZCORP, where he oversaw financial operations and capital markets activities, suggesting his expertise will positively impact Spectral AI.
- Market Reaction: Despite the announcement of the new appointment, Spectral AI's shares fell by 1.20%, reflecting a cautious market sentiment regarding the company's future financial performance, which may affect investor confidence.
- Strategic Implications: McGuire's appointment not only enhances the company's financial management capabilities but may also support future capital market activities and strategic initiatives, helping the company maintain its competitive edge in a challenging market.
- Executive Appointment: Spectral AI has announced the appointment of David McGuire as Chief Financial Officer, effective May 4, 2026, aiming to strengthen the company's financial leadership and strategic readiness for the commercialization of the DeepView® System.
- Extensive Experience: McGuire brings over 20 years of finance and accounting experience, having held executive roles at Solo Brands and EZCORP, where he oversaw financial reporting, internal controls, and capital markets activities, which is expected to positively impact Spectral AI's financial infrastructure.
- Strategic Goals: McGuire expressed his eagerness to collaborate with the team to advance the company's strategic priorities and enhance long-term shareholder value, indicating the company's confidence and commitment to future growth.
- Technological Innovation: Spectral AI's DeepView System aims to revolutionize wound care management by providing objective assessments of burn wound healing potential, expected to improve patient outcomes and reduce healthcare costs, further solidifying its position in the health tech sector.
Overview of Spectral AI: Spectral AI is a company focused on developing advanced artificial intelligence solutions, particularly in the field of healthcare and diagnostics.
Leadership Appointment: David McGuire has been appointed as the Chief Financial Officer (CFO) of Spectral AI, bringing extensive experience in financial management and strategic planning.
Future Goals: The company aims to enhance its operational efficiency and expand its market presence under McGuire's financial leadership.
Impact on Healthcare: Spectral AI's innovations are expected to significantly improve diagnostic processes and patient outcomes in the healthcare sector.








